STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Companyโs principal products are ICLs used in refractive surgery, including its EVO family of lenses.
์ข
๋ชฉ ์ฝ๋ STAA
ํ์ฌ ์ด๋ฆSTAAR Surgical Co
์์ฅ์ผFeb 24, 1992
CEOFarrell (Stephen C)
์ง์ ์1157
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃFeb 24
์ฃผ์1911 Walker Ave
๋์MONROVIA
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ91016
์ ํ16263037902
์น์ฌ์ดํธhttps://www.staar.com/
์ข
๋ชฉ ์ฝ๋ STAA
์์ฅ์ผFeb 24, 1992
CEOFarrell (Stephen C)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์